Should You Buy, Sell or Hold AMAT Stock After a 72.5% YTD Rise?

Applied Materials (AMAT) is up 72.5% YTD, and Zacks flags continued AI-driven semiconductor capex as the core support for growth. The article highlights expansion across advanced packaging (projected >70% revenue growth in calendar 2026), DRAM/HBM momentum (HBM-related DRAM revenues +52% YoY in fiscal Q3), and recurring Applied Global Services with record Q3 revenue of $1.78B (+22% YoY) and 35.6% gross margin. Despite the stock trading at a premium (P/S 8.04x vs. industry 4.96x; valuation flagged as overvalued with a D value score), it points to Q4 fiscal 2026 non-GAAP EPS of $4.02 (+/- $0.20) implying ~85% YoY growth and upward estimate revisions over the past 30 days, concluding with a “Buy/accumulate” stance.

Analysis

AMAT’s real advantage is not just exposure to AI spend, but being one of the few tool vendors that can monetize both the buildout and the productivity phase of the cycle. If advanced packaging and HBM stay tight, the installed-base/service mix should keep margins resilient even if new-system orders normalize, which makes the earnings path more durable than the headline multiple suggests. The catch is that the market is already paying for a multi-year growth runway, so the stock now needs execution on both revenue and mix to avoid de-rating.

Relative winners are likely the broad-capex names that can sell into customers trying to reduce vendor count; that favors AMAT over narrower point solutions if procurement gets stricter. The flip side is that specialized metrology/inspection and etch peers can still win share in their niches, so KLAC and LRCX should not be treated as direct substitutes—AMAT’s outperformance only persists if it keeps converting portfolio breadth into wallet share. Smaller packaging-adjacent names are the most vulnerable to being standardized out when customers consolidate toolsets.

Near term, the stock is most sensitive to whether the next round of memory and foundry capex commentary confirms 2026-27 spend rather than just backlogs and announcements. Over 6-18 months, the key falsifier is any evidence that fab ramps slip, HBM pricing weakens, or service growth decelerates below the company’s implied trajectory; that would compress an 8x sales multiple quickly. The consensus may be underestimating how much of the upside is already in the shares, making this more of a quality compounder than an obvious outright long at current valuation.

Key Decisions for Investors

• Avoid chasing AMAT outright here; wait for a pullback or a post-earnings reset before adding. At 8x sales, upside needs continued estimate revisions, while any guide miss could compress toward the peer multiple fast.
• Pair trade: long KLAC / short AMAT over 1-3 months if you want AI-capex exposure with lower valuation risk. KLAC has cleaner yield-control leverage and less downside if tool spending broadens but growth slows.
• If holding AMAT, consider a defined-risk bull call spread instead of stock ahead of the next catalyst window. This captures continuation to the next estimate revision while limiting damage if the multiple mean-reverts.
• Watch for a short signal in CAMT if customers consolidate advanced packaging/metrology spend around larger vendors. The thesis breaks if CAMT starts printing outsized packaging wins or if AMAT’s packaging growth is slower than management’s >70% framing.